Prolotherapy vs PRP: Which Is Right for Your Joint Pain?

Prolotherapy vs PRP comes down to mechanism: prolotherapy injects hypertonic dextrose (12.5 to 25% sugar water) to provoke a short, controlled inflammatory repair response, while PRP (platelet-rich plasma) injects a concentrate of your own platelets, at 3 to 8 times normal levels, that carries growth factors straight into damaged tissue. PRP has the stronger research base for tendinopathy and knee osteoarthritis, prolotherapy has its best case in ligament laxity and ligament-related back pain, and both are cash-pay, off-label injections whose evidence is still mixed.

If you are dealing with chronic joint pain, the kind that physical therapy has not fully resolved and surgery feels premature for, you have probably come across both prolotherapy and PRP. They sit in the same regenerative medicine category, they are both injection-based, and they both aim to help your body repair tissue that has stopped healing on its own. They work through different mechanisms, they cost very different amounts, and the evidence favors each one for different conditions.

What follows is a head-to-head comparison with no sales pitch for either side: the mechanisms, the evidence by condition, the costs, how prolotherapy and PRP compare with stem cell therapy, and a practical decision framework for working out which one (or both) makes sense for your situation.

How They Work: Two Different Paths to the Same Goal

Prolotherapy: Controlled inflammation as a repair signal

Prolotherapy (proliferation therapy) injects a solution, most commonly hypertonic dextrose (12.5-25% sugar water), into damaged ligaments, tendons, or joint capsules. The dextrose creates a mild, controlled inflammatory response at the injection site. This inflammation is the point: it recruits growth factors, fibroblasts, and immune cells to an area that has stopped healing on its own.

Think of it as restarting a stalled repair process. Chronic injuries often get stuck in a cycle where the initial inflammatory response has subsided, but the tissue never fully healed. Prolotherapy restarts that inflammatory cascade, giving your body another chance to complete the repair.

A typical session involves multiple injections (sometimes 10-20+) at precise points along the damaged structure. Sessions are spaced 3-6 weeks apart, and most patients need 3-6 sessions.

Dextrose is the most common solution, but some practitioners use other proliferants, such as P2G (a mix of phenol, glycerin and glucose) or sodium morrhuate, and most add a local anesthetic such as lidocaine. The prolotherapy treatment guide covers the solutions, the injection technique and what a full course looks like.

PRP: Concentrated growth factors delivered directly

Platelet-Rich Plasma starts with a blood draw (typically 30-60 mL). Your blood is centrifuged to separate the platelets from red blood cells and plasma. The resulting PRP concentrate contains 3-8x the normal platelet concentration, and platelets are packed with growth factors: PDGF, TGF-beta, VEGF, IGF-1, and others.

This concentrated growth factor solution is then injected directly into the damaged tissue. Unlike prolotherapy, PRP does not rely on creating inflammation as a middleman. It delivers the repair signals directly.

PRP preparation quality varies significantly between clinics. The centrifuge system, spin protocol, and whether leukocytes (white blood cells) are included or excluded all affect the final product. This is one of the reasons PRP research is hard to standardize, “PRP” from one clinic may be very different from “PRP” at another.

Researchers usually split PRP into leukocyte-rich PRP (LR-PRP), which keeps white blood cells and tends to cause more post-injection soreness, and leukocyte-poor PRP (LP-PRP), which is more often used inside arthritic joints. Our platelet-rich plasma therapy guide explains the preparation steps in more detail.

Is PRP more potent than prolotherapy?

PRP is usually described as the more potent of the two because it delivers a measured dose of growth factors rather than prompting the body to recruit its own. Potency here means biological signal per injection, not a better result: no large head-to-head trial shows that PRP reliably outperforms dextrose prolotherapy for the same condition.

How potent a given PRP injection is depends on the platelet concentration, the leukocyte content and the volume injected, which all vary by clinic and device. A practitioner who can tell you which system they use and roughly what concentration it produces is giving you useful information about the product you are paying for.

Evidence Comparison by Condition

This is where it gets practical. The evidence does not favor one treatment universally, it depends on what you are treating.

What the Key Studies on Prolotherapy and PRP Found

A handful of named trials and reviews shape most of what clinicians say about these two injections. Reading them directly is the quickest way to see where the evidence is solid and where it is thin.

Prolotherapy studies

• Knee osteoarthritis: Rabago and colleagues (Annals of Family Medicine, 2013) randomized adults with knee osteoarthritis to dextrose prolotherapy, saline injections or at-home exercise, and found greater improvement in pain, function and stiffness scores with dextrose at 52 weeks.
• Low back pain: Ongley and colleagues (The Lancet, 1987) reported benefit when sclerosant injections were combined with spinal manipulation and exercise. Yelland and colleagues (Spine, 2004) found that both dextrose and saline injection groups improved, with no meaningful difference between them.
• Overall back pain evidence: A Cochrane review by Dagenais and colleagues (2007) concluded that prolotherapy alone is not an effective treatment for chronic low back pain, but that it may help when combined with manipulation, exercise and other co-interventions.

PRP studies

• Tennis elbow: Peerbooms and colleagues (American Journal of Sports Medicine, 2010) found that a single PRP injection reduced pain and improved function more than a corticosteroid injection at one year in lateral epicondylitis.
• Knee osteoarthritis: The RESTORE trial by Bennell and colleagues (JAMA, 2021) gave three leukocyte-poor PRP or saline injections and found no significant difference in knee pain or medial tibial cartilage volume at 12 months.
• Guideline view: The 2019 American College of Rheumatology and Arthritis Foundation osteoarthritis guideline by Kolasinski and colleagues (Arthritis Care and Research, 2020) strongly recommends against PRP for knee and hip osteoarthritis and conditionally recommends against prolotherapy, citing heterogeneous preparations and inconsistent results.

Direct comparisons of prolotherapy and PRP in the same patients are limited to small trials, mostly in knee osteoarthritis and tendon conditions. That gap is why the table above describes which injection is favored for a condition rather than declaring an overall winner, and why your diagnosis matters more than the label on the syringe.

Cost Comparison: The Practical Reality

Cost is often the deciding factor, and the difference is substantial:

For patients who need treatment in multiple joints, say, both knees, both SI joints, and several spinal ligaments, prolotherapy’s lower per-session cost makes it far more accessible. Treating five areas with PRP could cost $5,000-$10,000; prolotherapy might accomplish similar coverage for $1,000-$3,000.

Prices vary with the region, the number of areas injected and whether ultrasound guidance is included, so ask any clinic for an all-in quote per session and for the full course. The breakdown of PRP injection costs walks through the line items that change the price.

Can PRP and Prolotherapy Be Used Together?

Yes, PRP and prolotherapy are often used together, either in the same visit or one after the other. The usual pattern is dextrose prolotherapy for the stabilizing ligaments around a joint and PRP for the single structure that is most damaged, such as a partially torn tendon or an arthritic knee compartment.

A second pattern is sequential: a course of prolotherapy first, then PRP for any area that improved but did not fully settle. Either way, combination protocols rest on clinical reasoning rather than dedicated trials, so ask the clinician why each injection goes where it does and how they will judge whether it worked.

Prolotherapy vs Stem Cell Therapy: Where Each Fits

Stem cell therapy sits a step beyond PRP in cost and regulatory complexity. In US orthopedic practice it usually means bone marrow aspirate concentrate (BMAC) taken from the hip bone or cells processed from your own fat tissue, injected the same day. Prolotherapy uses an inexpensive dextrose solution and no tissue harvest at all.

The evidence does not support stem cell injections as a stronger option for joint pain. The same 2019 ACR guideline strongly recommends against stem cell injections for knee and hip osteoarthritis, and the U.S. Food and Drug Administration (FDA) has not approved any stem cell product for orthopedic conditions. Many patients try prolotherapy or PRP first and consider cell-based options only after a specialist review. Our stem cell therapy treatment guide and the comparison of PRP and stem cell therapy go further into that decision.

When Prolotherapy Is the Better Choice

Prolotherapy tends to be the better fit when:

• Ligament laxity or joint instability is the primary problem, this is prolotherapy’s strongest indication
• Multiple joints need treatment, the lower cost per session makes complete treatment feasible
• Budget is a significant factor, prolotherapy costs 40-70% less than PRP
• SI joint dysfunction or ligamentous back pain, the best evidence for back-related prolotherapy
• Hypermobility or connective tissue laxity (e.g., Ehlers-Danlos spectrum), prolotherapy can tighten loose ligaments over multiple sessions
• You want a well-established treatment, prolotherapy has been used since the 1930s with a long safety track record

For back-specific use, the guide to prolotherapy for back pain covers the sacroiliac and posterior ligament injections in more depth, and the SI joint pain condition page explains how that diagnosis is usually confirmed.

When PRP Is the Better Choice

PRP tends to be the better fit when:

• Tendinopathy is the primary diagnosis, PRP’s growth factor profile is well-matched to tendon repair
• Moderate knee or hip osteoarthritis, the strongest PRP evidence is here
• Single-joint focus, when you are treating one specific area and want the most potent intervention
• You want fewer sessions, PRP often requires 1-3 treatments vs. 3-6 for prolotherapy
• Previous prolotherapy had partial response, PRP can be a step up in potency for areas that improved but did not fully resolve
• Athletic injury with specific tendon or cartilage damage, PRP’s growth factors target the specific tissue repair needed

Even in knee osteoarthritis, where PRP is most often offered, trial results conflict, as the RESTORE trial showed. The osteoarthritis condition page sets PRP alongside exercise, weight management and other injection options, and the tennis elbow overview covers the tendon condition where PRP has some of its better trial data.

Decision Framework: Choosing Your Path

Here is a practical way to think through the decision:

Step 1: Define the primary problem. Is it ligament laxity/instability? Lean toward prolotherapy. Tendinopathy? Lean toward PRP. Osteoarthritis? Either can work, consider budget and severity.

Step 2: Count the treatment areas. One joint? PRP is feasible. Multiple joints or widespread ligament issues? Prolotherapy’s economics make more sense.

Step 3: Consider your budget. If cost is a significant constraint, prolotherapy offers regenerative treatment at a fraction of PRP’s price. It is better to complete a full prolotherapy course than to afford only one PRP session when three are needed.

Step 4: Evaluate severity. Mild to moderate pathology? Start with prolotherapy. Moderate to severe, or prolotherapy has already been tried? PRP or combination therapy.

Step 5: Find the right provider. A skilled practitioner matters more than the choice of injectable. An experienced prolotherapist will outperform an inexperienced PRP provider every time. Ask about their training, volume of cases, and what imaging guidance they use.

Both injections are usually given by sports medicine physicians, physiatrists (physical medicine and rehabilitation doctors), orthopedic surgeons, pain specialists and some naturopathic or osteopathic physicians, often with ultrasound guidance. You can compare clinics that offer PRP injections by state and city, many of which also list prolotherapy. Listing order on Regenerated.com is not paid ranking, Featured slots are labeled and capped, Verified means a clinic passed credential checks rather than paid more, and the directory is free for patients. Being listed is not an endorsement, so the questions above still apply; the guide to Featured, Verified and organic listings explains each label.

Frequently Asked Questions

Is one more painful than the other?

PRP usually causes more soreness afterward, while prolotherapy usually involves more needle sticks. Prolotherapy sessions often involve more individual injections (10-20+), but each injection is small. PRP typically involves fewer injection sites but may cause more post-injection soreness because the platelet concentrate creates a stronger inflammatory response. Most patients rate both as tolerable, a 4-6 out of 10 during the procedure, with soreness lasting 2-5 days afterward. Neither requires general anesthesia.

How long before I see results?

Both therapies work on biological timelines, so expect weeks to months rather than days. With prolotherapy, initial improvement is often noticeable after 2-3 sessions (6-12 weeks into treatment), with full results after completing the series. With PRP, many patients notice improvement at 4-8 weeks, with continued gains over 3-6 months as tissue remodeling progresses. Neither provides overnight relief, and the injected area usually needs a rehabilitation program alongside it.

Can I do prolotherapy first and then switch to PRP if needed?

Yes, starting with prolotherapy and stepping up to PRP is a common and sensible sequence. A typical plan is 3-4 prolotherapy sessions, then PRP for any area that showed partial improvement but did not fully settle. The prolotherapy is not wasted: the ligament stabilization it provides creates a better foundation for PRP to work on the remaining damage. Ask your clinician how they will measure progress before deciding to switch.

Are there conditions where neither is appropriate?

Yes. Neither injection is appropriate with an active infection at the injection site, and anticoagulation therapy is a relative contraindication. Certain blood and platelet disorders rule out PRP. Conditions that need surgery, such as complete tendon tears, advanced bone-on-bone arthritis or structural instability requiring reconstruction, are poor candidates for both. Prolotherapy and PRP work best for partial injuries and early to moderate degenerative changes, not end-stage joint damage.

Is prolotherapy or PRP better for knee osteoarthritis?

Neither is clearly better for knee osteoarthritis, and both have mixed evidence. Dextrose prolotherapy beat saline and exercise in a 2013 randomized trial by Rabago and colleagues, while PRP did no better than saline in the 2021 RESTORE trial in JAMA, even though other meta-analyses favor PRP over hyaluronic acid. The 2019 ACR guideline advises against both for knee osteoarthritis. Cost, severity and how many areas need treatment usually decide the choice in practice.

Does insurance cover prolotherapy or PRP?

Insurance rarely covers either prolotherapy or PRP, so most patients pay cash. Medicare does not cover prolotherapy, and most private insurers treat both injections as investigational for joint and tendon conditions. Prolotherapy typically runs $200 to $600 per session and PRP $500 to $2,000 per session. Ask the clinic for a written quote for the full course and an itemized receipt, and check with your plan administrator whether a health savings account can be used.

Related Reading

• Prolotherapy: Complete Guide, our complete pillar covering prolotherapy mechanisms, evidence, and what to expect
• Joint Pain: Complete Guide, the full overview of joint pain causes, diagnosis, and treatment options
• Stem Cell Therapy, the next step up in regenerative medicine for those who need more than PRP